Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Highland Credit Strategies Fund was a non-diversified, closed-end management investment company based in Dallas, Texas. Managed by Highland Capital Management Fund Advisors, the fund's primary objective was to provide a high level of current income through investments in floating rate loans and other debt securities. The fund's portfolio typically included senior secured loans, high-yield corporate bonds, and structured products across various industries, including healthcare. In November 2017, the fund was merged into the Highland Income Fund (HFRO) to consolidate Highland's closed-end fund offerings. As a credit-focused investment vehicle, it did not engage in direct drug discovery, clinical development, or life science research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Highland Credit Strategies Fund.